An Open-Label Study to Evaluate the Safety and Effect on Disease Progression and Overall Survival of Avastin Plus Taxane-Based Chemotherapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

Trial Profile

An Open-Label Study to Evaluate the Safety and Effect on Disease Progression and Overall Survival of Avastin Plus Taxane-Based Chemotherapy in Patients With Locally Recurrent or Metastatic Breast Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Antineoplastics; Taxanes
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Acronyms ATHENA
  • Sponsors Roche
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register; DRKS00003642).
    • 23 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by Roche website.
    • 23 Feb 2010 Status changed from active, no longer recruiting to recruiting as reported by Roche website.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top